News overview Healthcare & Biotech

ImmunityBio is once again attracting attention thanks to progress on Anktiva and anticipated data from its immunotherapy pipeline, particula...

IBRX 10 hours ago

9.75 0.62 %

Sanofi is among the pharmaceutical groups that will have to contend with several patent losses in the coming years, a risk that could increa...

SAN yesterday

71.52 0.83 %

Intuitive Surgical retains a dominant position in robotic surgery, with a 20% increase in international procedures and growth prospects in I...

ISRG 6 days ago

423.96 2.06 %

NewAmsterdam Pharma has dosed the first participant in the Phase 2b SPINOZA study, which is evaluating obicetrapib in adults with biomarkers...

NAMS 1 week ago

21.38 0.56 %

Sanofi and Regeneron are strengthening their partnership in type 2 inflammatory diseases through four long-acting antibody programs. The agr...

SAN 1 week ago

71.52 0.83 %

Novo Nordisk has signed an exclusive agreement with Hengrui Pharma worth up to $2.6 billion for a once-weekly oral treatment targeting obesi...

NVO 1 week ago

38.26 1.95 %